Literature DB >> 12591566

Functional magnetic resonance imaging of tonic pain and vasopressor effects in rats.

U I Tuor1, E McKenzie, B Tomanek.   

Abstract

In functional magnetic resonance imaging (fMRI) studies, an elevation in blood pressure (BP) in individuals with a poor autoregulatory response may increase cerebral blood flow, potentially enhancing the blood oxygenation level dependent response. To investigate the role of BP changes, the cerebral activation to either tonic pain or the infusion of the vasopressor norepinephrine was correlated with the accompanying BP changes in alpha-chloralose anesthetized rats. Immediately after formalin (2%) injection into the forepaw, fMRI detected an activation that was correlated with the BP increase and additional activations that were independent of blood pressure changes 5-40 minutes later. The activation detected with the administration of the vasopressor norepinephrine, which does not cross the blood-brain barrier was correlated to both the amount and rate of increase in BP. The response ranged from being sparse, localized within cortex or widespread during modest, moderate or severe elevations in BP, respectively. The cerebral circulatory effects of hypertension should be considered as contributing to changes in cerebral blood oxygenation in fMRI studies involving increases in BP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12591566     DOI: 10.1016/s0730-725x(02)00599-4

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  17 in total

Review 1.  A model for lupus brain disease.

Authors:  Betty Diamond; Bruce T Volpe
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast.

Authors:  Neil Easton; Yasmene B Shah; Fiona H Marshall; Kevin C Fone; Charles A Marsden
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

3.  Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.

Authors:  Duncan J Hodkinson; Carmen de Groote; Shane McKie; J F William Deakin; Steve R Williams
Journal:  Br J Med Med Res       Date:  2012-09

4.  Endogenous opioid-dopamine neurotransmission underlie negative CBV fMRI signals.

Authors:  Yen-Yu I Shih; Yun-Chen Chiang; Bai-Chuang Shyu; Fu-Shan Jaw; Timothy Q Duong; Chen Chang
Journal:  Exp Neurol       Date:  2012-01-05       Impact factor: 5.330

5.  CNS animal fMRI in pain and analgesia.

Authors:  David Borsook; Lino Becerra
Journal:  Neurosci Biobehav Rev       Date:  2010-11-30       Impact factor: 8.989

Review 6.  Methodological considerations in rat brain BOLD contrast pharmacological MRI.

Authors:  C A Steward; C A Marsden; M J W Prior; P G Morris; Y B Shah
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

7.  Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats.

Authors:  Y B Shah; L Haynes; M J W Prior; C A Marsden; P G Morris; V Chapman
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

8.  The phenylephrine blood pressure clamp in pharmacologic magnetic resonance imaging: reduction of systemic confounds and improved detectability of drug-induced BOLD signal changes.

Authors:  Raffael Kalisch; Marina Delfino; M Gustavo Murer; Dorothee P Auer
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

9.  Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings.

Authors:  Helen C Fox; Dongju Seo; Keri Tuit; Julie Hansen; Anne Kimmerling; Peter T Morgan; Rajita Sinha
Journal:  J Psychopharmacol       Date:  2012-01-09       Impact factor: 4.153

10.  Immunity and behavior: antibodies alter emotion.

Authors:  Patricio T Huerta; Czeslawa Kowal; Lorraine A DeGiorgio; Bruce T Volpe; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.